N-(3-(3-Methoxyphenyl)-5,5-dioxidotetrahydrothieno[3,4-d]thiazol-2(3H)-ylidene)-3-nitrobenzamide

Catalog No. :
ACYJZI516
CAS No. :
618396-86-4
Molecular Formula :
C19H17N3O6S2
Molecular Weight :
447.49

IUPAC Name:(E)-N-(3-(3-methoxyphenyl)-5,5-dioxidotetrahydrothieno[3,4-d]thiazol-2(3H)-ylidene)-3-nitrobenzamide

N-(3-(3-Methoxyphenyl)-5,5-dioxidotetrahydrothieno[3,4-d]thiazol-2(3H)-ylidene)-3-nitrobenzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(3-(3-Methoxyphenyl)-5,5-dioxidotetrahydrothieno[3,4-d]thiazol-2(3H)-ylidene)-3-nitrobenzamide
IUPAC Name(E)-N-(3-(3-methoxyphenyl)-5,5-dioxidotetrahydrothieno[3,4-d]thiazol-2(3H)-ylidene)-3-nitrobenzamide
Molecular FormulaC19H17N3O6S2
Molecular Weight447.49
SMILESCOC1=CC(N2/C(=N\C(=O)C3=CC=CC([N+](=O)[O-])=C3)SC3CS(=O)(=O)CC32)=CC=C1
InChI KeySFOHKTWWJPDYTC-FMQUCBEESA-N
Synonym3-nitro-N-(3-(3-methoxyphenyl)-5,5-dioxidotetrahydrothieno[3,4-d][1,3]thiazol-2(3H)-ylidene)benzamide;(E)-N-(3-(3-methoxyphenyl)-5,5-dioxidotetrahydrothieno[3,4-d]thiazol-2(3H)-ylidene)-3-nitrobenzamide;Benzamide, 3-nitro-N-[tetrahydro-3-(3-methoxyphenyl)-5,5-dioxidothieno[3,4-d]thiazol-2(3H)-ylidene]-
CAS No.618396-86-4

Synthetic Route by SureRoute

1. ACYJZI516 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYJZI516 route product structure diagram
    ACYJZI516618396-86-4
Inquiry

2. ACYJZI516 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYJZI516 route product structure diagram
    ACYJZI516618396-86-4
Inquiry

Comments (0)